Veradermics (MANE) Total Current Liabilities (2024 - 2026)

Veradermics has reported Total Current Liabilities for 3 years, with the latest figure at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities changed N/A year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (changed N/A YoY), and the FY2025 full-year result was $9.2 million, up 93.98% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $6.7 million, down from $9.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $9.2 million in Q4 2025, with the low at $4.7 million in Q4 2024.
• Historically, Total Current Liabilities has averaged $6.9 million across 3 years, with a median of $6.7 million in 2026.
• The largest YoY upside for Total Current Liabilities was 93.98% in 2025 against a maximum downside of 93.98% in 2025.
• Veradermics' Total Current Liabilities stood at $4.7 million in 2024, then surged by 93.98% to $9.2 million in 2025, then declined by 26.62% to $6.7 million in 2026.
• The last three Total Current Liabilities figures came in at $6.7 million (Q1 2026), $9.2 million (Q4 2025), and $4.7 million (Q4 2024), per Business Quant data.